2012
DOI: 10.1177/175114371201300418
|View full text |Cite
|
Sign up to set email alerts
|

Corticosteroid after Etomidate in Critically Ill Patients

Abstract: In this prospective, single-centre, slightly underpowered, double-blind randomised controlled trial (RCT) with intention-to-treat analysis, use of moderate-dose hydrocortisone in etomidate-related adrenal insufficiency was not shown to reduce the proportion of patients with a cardiovascular Sequential Organ Failure Assessment (SOFA) score of 3 or 4. Level of evidence: 2B (CEBM, low quality RCT)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Of the seven studies, six assessed mortality (72–77); however, the corticosteroid used, dose, frequency, and duration of administration were not consistent across studies. There were two separate RCTs (72, 73).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Of the seven studies, six assessed mortality (72–77); however, the corticosteroid used, dose, frequency, and duration of administration were not consistent across studies. There were two separate RCTs (72, 73).…”
Section: Resultsmentioning
confidence: 99%
“…Of the seven studies, six assessed mortality (72–77); however, the corticosteroid used, dose, frequency, and duration of administration were not consistent across studies. There were two separate RCTs (72, 73). In one study patients received a 42-hour infusion of hydrocortisone 200 mg/day (350 mg total) (72) and in another trial, a 42-hour infusion of hydrocortisone (200 mg total) was administered (73) following etomidate administration for RSI.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations